Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 16/20 | 0.42 |
| ▸ | RAB9A | P51151 | 16/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.42 |
| ▸ | HPGD | P15428 | 6/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | MECP2 | P51608 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10112434 | 0.93 | NPC1 (0.42) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL10112683 | 0.88 | NPC1 (0.37) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL10112437 | 0.87 | RAB9A (0.41) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL8406139 | 0.87 | ALDH1A1 (0.35) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL8406124 | 0.87 | ALDH1A1 (0.37) | HPGDKMT2APOLBMEN1KDM4E | |
| SCHEMBL10112566 | 0.84 | NPC1 (0.34) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL14465414 | 0.84 | NPC1 (0.53) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13615833 | 0.84 | ALDH1A1 (0.39) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL27998248 | 0.84 | ACHE (0.35) | HPGDPOLBKDM4EALDH1A1MAPT | |
| SCHEMBL21090317 | 0.83 | NPC1 (0.49) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110980-B2 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-8110980-B2 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100164376-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-07-01 | — | — | US | disclosed |
| US-20100164376-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-07-01 | — | — | US | disclosed |
| US-7674914-B2 | novel anthracene derivative represented by General Formula (1) is provided, which enables the production of a light-emitting element with high luminous efficiency and a long lifetime. A high-performance light-emitting device and electronic device in which the anthracene derivative light emitting diode | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-03-09 | — | — | US | disclosed |
| US-7674914-B2 | novel anthracene derivative represented by General Formula (1) is provided, which enables the production of a light-emitting element with high luminous efficiency and a long lifetime. A high-performance light-emitting device and electronic device in which the anthracene derivative light emitting diode | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-05-01 | — | — | US | disclosed |
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | AMY1A, CYP1A1, CRY1 | NPC1 3526/4885RAB9A 2483/4885SMN1; SMN2 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.